| Sudhakar Venkata Mallela Md Inc | |
|
6885 Brockton Ave Riverside CA 92506-3811 | |
| (702) 256-3637 | |
| Not Available |
| Full Name | Sudhakar Venkata Mallela Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 6885 Brockton Ave, Riverside, California |
| Authorized Official Name and Position | Sudhakar Venkata Mallela (PRESIDENT) |
| Authorized Official Contact | 7022563637 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sudhakar Venkata Mallela Md Inc 6885 Brockton Ave Riverside CA 92506-3811 Ph: () - | Sudhakar Venkata Mallela Md Inc 6885 Brockton Ave Riverside CA 92506-3811 Ph: (702) 256-3637 |
| NPI Number | 1518411636 |
|---|---|
| Provider Enumeration Date | 08/05/2016 |
| Last Update Date | 07/17/2018 |
| Medicare PECOS PAC ID | 9830485663 |
|---|---|
| Medicare Enrollment ID | O20160902002087 |
News Archive
Modern Healthcare reports that today's the last day to sign up for the Centers for Medicare and Medicaid Services' ACO program, which starts in April. Politico Pro, meanwhile, reports that a coalition of state hospitals is pushing the White House to address what they see as a "gaming of Medicare payments" that allows Massachusetts hospitals to collect higher Medicare reimbursements than other states.
MAXIMUS, a leading provider of government services, announced today that it has acquired Canadian-based DeltaWare Systems, Inc. (DeltaWare), a premier developer of health administration management systems for the government health care market. Terms of the transaction were not disclosed.
The U.S. Food and Drug Administration today announced that an orthopedic device used in the knee should not have been cleared for marketing in the United States. The announcement follows a re-evaluation of the scientific evidence that was undertaken after a September 2009 agency report identified problems in the agency's review of the device.
With more than 36.9 million people infected globally, HIV continues to be a major public health issue. Those living with the virus are at an increased risk for other non-AIDS diseases, such as cardiovascular disease and cancer, and though it's not entirely clear why, this has been associated with inflammation and abnormal blood clotting.
A new biologic agent-the most potent of its kind so far-is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518411636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | (* (Not Available)) | Primary |
| Provider Name | Sudhakar V Mallela |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1851498729 PECOS PAC ID: 7517949662 Enrollment ID: I20150115001124 |
News Archive
Modern Healthcare reports that today's the last day to sign up for the Centers for Medicare and Medicaid Services' ACO program, which starts in April. Politico Pro, meanwhile, reports that a coalition of state hospitals is pushing the White House to address what they see as a "gaming of Medicare payments" that allows Massachusetts hospitals to collect higher Medicare reimbursements than other states.
MAXIMUS, a leading provider of government services, announced today that it has acquired Canadian-based DeltaWare Systems, Inc. (DeltaWare), a premier developer of health administration management systems for the government health care market. Terms of the transaction were not disclosed.
The U.S. Food and Drug Administration today announced that an orthopedic device used in the knee should not have been cleared for marketing in the United States. The announcement follows a re-evaluation of the scientific evidence that was undertaken after a September 2009 agency report identified problems in the agency's review of the device.
With more than 36.9 million people infected globally, HIV continues to be a major public health issue. Those living with the virus are at an increased risk for other non-AIDS diseases, such as cardiovascular disease and cancer, and though it's not entirely clear why, this has been associated with inflammation and abnormal blood clotting.
A new biologic agent-the most potent of its kind so far-is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.
› Verified 1 days ago
News Archive
Modern Healthcare reports that today's the last day to sign up for the Centers for Medicare and Medicaid Services' ACO program, which starts in April. Politico Pro, meanwhile, reports that a coalition of state hospitals is pushing the White House to address what they see as a "gaming of Medicare payments" that allows Massachusetts hospitals to collect higher Medicare reimbursements than other states.
MAXIMUS, a leading provider of government services, announced today that it has acquired Canadian-based DeltaWare Systems, Inc. (DeltaWare), a premier developer of health administration management systems for the government health care market. Terms of the transaction were not disclosed.
The U.S. Food and Drug Administration today announced that an orthopedic device used in the knee should not have been cleared for marketing in the United States. The announcement follows a re-evaluation of the scientific evidence that was undertaken after a September 2009 agency report identified problems in the agency's review of the device.
With more than 36.9 million people infected globally, HIV continues to be a major public health issue. Those living with the virus are at an increased risk for other non-AIDS diseases, such as cardiovascular disease and cancer, and though it's not entirely clear why, this has been associated with inflammation and abnormal blood clotting.
A new biologic agent-the most potent of its kind so far-is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.
› Verified 1 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |